> NBIX – They should likely be reporting on their meetings with FDA in that timeframe<
In that case, it’s reasonable to infer that the company does not expect positive developments from these meetings. If they did, they surely would not have scheduled the option re-pricing to occur after the news is released.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.